Working… Menu

Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02728492
Recruitment Status : Completed
First Posted : April 5, 2016
Last Update Posted : May 3, 2016
Janssen Pharmaceutica N.V., Belgium
Information provided by (Responsible Party):
NewVac LLC

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2015
Actual Study Completion Date : January 2016